GENE ONLINE|News &
Opinion
Blog

2026-06-03|

Highmark Health Sues HaloMD Over Alleged Deceptive Practices in No Surprises Act Arbitrations

by GOAI
Share To

Highmark Health has filed a lawsuit against the medical billing firm HaloMD, alleging that the company utilized deceptive tactics and misleading data to secure favorable outcomes in federal arbitration proceedings. This legal action marks the fourth instance of an insurance provider challenging HaloMD’s practices under the No Surprises Act, a federal law designed to resolve payment disputes between insurers and out-of-network providers. The lawsuit specifically seeks to overturn previous arbitration decisions that favored HaloMD, claiming the firm manipulated the dispute resolution process.

The complaint centers on allegations that HaloMD employed a “sham letter” and provided inaccurate data to influence independent dispute resolution entities. Highmark Health contends that these actions compromised the integrity of the arbitration process, which is intended to determine fair reimbursement rates for medical services. By challenging these specific arbitration wins, the insurer aims to invalidate the resulting payment mandates. This litigation follows a pattern of similar complaints from other major health insurers, who have also raised concerns regarding the methods HaloMD uses to navigate the No Surprises Act’s regulatory framework.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 3, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Insilico Medicine’s ISM8969 Enters Phase 1 Trial, Advancing Brain-Penetrant NLRP3 Inhibitor for Neuroinflammation and CNS Disorders
2026-06-18
PNC Multifamily Capital Launches $251.4 Million Affordable Housing Investment Fund
2026-06-18
ArcelorMittal, thyssenkrupp, and voestalpine Call for EU Emissions Trading System Reforms to Protect Steel Competitiveness
2026-06-18
Hillman Group and Hillwood Begin Construction on Dallas-Fort Worth Multipurpose Facility
2026-06-18
Six Taipei Biotechs Head to BIO 2026 in San Diego, With Precision Medicine, Drug Delivery, and Bioprocess Innovation in Focus
2026-06-18
2026 Tang Prize in Biopharmaceutical Science Honors Three Pioneers of “Living Drug” Immunotherapies
2026-06-17
How One South Korean Hospital Built a Global Reputation Around a $5 Billion Surgical Standard
2026-06-16
Scroll to Top